HUMANIGEN, INC
Profile
Company Names
HUMANIGEN, INC
KALOBIOS PHARMACEUTICALS INC
Addresses
533 AIRPORT BLVD., SUITE 400, BURLINGAME, CA 94010
1000 MARINA BOULEVARD, SUITE 250, BRISBANE, CA 94005-1878
442 LITTLEFIELD AVENUE, SOUTH SAN FRANCISCO, SOUTH SAN FRANCISCO, CA 94080
260 EAST GRAND AVE, SOUTH SAN FRANCISCO, CA 94080
Phone Numbers
650.243.3100
650-243-3100
(650) 243-3100
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS, OTHER
Year Incorporated:
> 5 years ago
State Incorporated:
DELAWARE
Total Amount Raised:
$39,177,614.00
Number of Funding Rounds:
6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2019-11-08
$494,614.00
$20,494,614.00
$20,000,000.00
Equity
5
2019-04-23
$1,300,000.00
$5,000,000.00
$3,700,000.00
Debt
4
2017-08-23
$15,000.00
$15,015,000.00
$15,000,000.00
Equity
3
2016-06-30
$12,150,000.00
$12,150,000.00
$0.00
Equity
2
2015-12-16
$8,218,000.00
$8,818,000.00
$600,000.00
Equity
1
2012-05-02
$17,000,000.00
$17,000,000.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
CAMERON
DURRANT
EXECUTIVE OFFICER, DIRECTOR
EZRA
FRIEDBERG
DIRECTOR
MICHAEL
HARRISON
DIRECTOR
SUPERWINCH HOLDINGS LLC
| TRADEWEB MARKETS LLC
| CORSA COAL CORP.
| TURING PHARMACEUTICALS AG
| KALOBIOS PHARMACEUTICALS INC
| OOFOS, LLC
| ORCHESTRA BIOMED, INC.
| FABLED COPPER CORP.
| SPROTT PRIVATE RESOURCE STREAMING + ROYALTY (US), LP
| ZYMTRONIX, INC.
| HYCROFT MINING HOLDING CORP
| OOFOS, INC.
| SHELFCYCLE INC.
JAMES
HEALY
DIRECTOR
GFP MANAGED EQUITIES I LP
| DXTERITY DIAGNOSTICS INC
| SORBENT THERAPEUTICS INC
| HYPERION THERAPEUTICS INC
| DFMSIM INC
| SOFINNOVA VENTURE PARTNERS VIII, L.P.
| KALOBIOS PHARMACEUTICALS INC
| GRAN PARADISO CAPITAL PARTNERS, LLC
| ASCENDIS PHARMA A/S
| CAPRA IBEX CLO INVESTOR, LLC
| BOLT BIOTHERAPEUTICS, INC.
| SOFINNOVA SYNERGY MASTER FUND, LP
| ARRIVENT BIOPHARMA, INC.
| ATSENA THERAPEUTICS, INC.
| BIOAGE LABS, INC.
DENNIS
HENNER
DIRECTOR
TED
LOVE
DIRECTOR
GARY
LYONS
DIRECTOR
DAVID
MORADI
DIRECTOR
TIMOTHY
MORRIS
DIRECTOR
DAVID
PRITCHARD
EXECUTIVE OFFICER, DIRECTOR
BRIGITTE
SMITH
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2019-11-08
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2019-04-23
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2017-08-23
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2016-06-30
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2015-12-16
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

